Document Classification

Section Type: RESULTS

Text: By contrast, when compared with baseline values, subjects treated with n-3 PUFA had significant improvement in FMD (9. 1 + / -5. 8 % vs. 11. 7 + / -4. 4 %, p = 0. 02) that was accompanied by decreased plasma triglycerides (117 + / -73 mg/dl vs. 86 + / -44 mg/dl, p = 0. 001) and TNF-alpha levels (8. 9 + / -2. 3 pg/ml vs. 6. 8 + / -2. 7 pg/ml, p = 0. 001), and a trend towards increased plasma adiponectin levels (7. 8 + / -4. 5 microg/ml vs. 9. 5 + / -5. 1 microg/ml, p = 0. 09).